Evaluating RELiZORB Use for the Treatment of Feeding Intolerance in Adults With Moderate to Severe Acute Pancreatitis
Evaluating RELiZORB Use for the Treatment of Feeding Intolerance in Adults With Moderate to Severe Acute Pancreatitis
Enrolling by invitation · NCT07583342 · Registry updated 2026-05-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluating RELiZORB Use for the Treatment of Feeding Intolerance in Adults With Moderate to Severe Acute Pancreatitis | Digestive System Diseases, pancreas disorder, pancreatitis | Enrolling by invitation | Phase 4 | 2026-05-13 | NCT07583342 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Alcresta Therapeutics, Inc. | 5 |
| Northwell Health | 107 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Lenox Hill Hospital | Manhattan | United States | 1 |
| Long Island Jewish Medical Center | New Hyde Park | United States | 49 |
| North Shore University Hospital | Manhasset | United States | 70 |
| South Shore University Hospital | Bay Shore | United States | 12 |
| Staten Island University Hospital | Staten Island | United States | 42 |